AllPlayers competitors

Zippia score 3.3

Competitor Summary. See how AllPlayers compares to its main competitors:

Keas has the most employees (75).

Work at AllPlayers?

Share your experience

AllPlayers vs competitors

Company	Founding date	Zippia score	Headquarters	# of Locations	Revenue	Employees
AllPlayers	-	3.3	Irving, TX	1	$690,000	50
ENGAGE International	-	4.4	Barrington, IL	1	$260,000	5
Icb International Inc	-	4.2	Los Angeles, CA	1	$900,000	12
Brightline	-	4.3	New York, NY	1	$1.5M	20
Keas	-	4.3	San Francisco, CA	1	$6.4M	75
HLR Inc	-	3.9	Boulder, CO	1	-	-
Glocal Initiative	-	3.7	San Diego, CA	1	$250,000	50
Indie Inc	-	3.7	-	-	$170,000	5

Rate how well AllPlayers differentiates itself from its competitors.

AllPlayers salaries vs competitors

Compare AllPlayers salaries vs competitors

Company	Average salary	Hourly salary	Salary score
AllPlayers	$61,496	$29.57	-

Compare AllPlayers job title salaries vs competitors

Company	Highest salary	Hourly salary
AllPlayers	$70,474	$33.88
HLR Inc	$70,526	$33.91
ENGAGE International	$70,495	$33.89
Brightline	$70,482	$33.89
Icb International Inc	$70,468	$33.88
Keas	$70,449	$33.87
Indie Inc	$70,444	$33.87
Glocal Initiative	$70,428	$33.86

Do you work at AllPlayers?

Does AllPlayers effectively differentiate itself from competitors?

AllPlayers jobs

AllPlayers demographics vs competitors

Compare gender at AllPlayers vs competitors

Job title	Male	Female
Brightline	59%	41%
AllPlayers	-	-

Male

Female

100%

75%

50%

25%

AllPlayers

Brightline

25%

50%

75%

100%

Compare race at AllPlayers vs competitors

Company	White	Hispanic or Latino	Black or African American	Asian	Unknown	Diversity score
Brightline	58%	12%	13%	13%	3%	9.7

AllPlayers and similar companies CEOs

CEOBio

Ram Bhatt

Icb International Inc

Bhatt is a veteran of the biotechnology industry with more than 30 years of experience in pharmaceutical development and diagnostics. At Hoffman-La Roche, he developed human IL-2, gamma-Interferon and Human Growth Hormone Releasing Factor pharmaceuticals. He developed a diagnostic for sexually transmitted diseases and the key components of HPA technology, which generate more than $500 million a year in commercial diagnostic revenue for Gen-Probe. For Biocept, Dr. Bhatt developed a non-invasive diagnostic test for fetal RhD genotyping and a fetal gender-determination test from maternal blood at eight to nine weeks gestation. He invented and developed a novel device to capture and analyze circulating fetal cells and tumor cells to diagnose prenatal disorders and cancers. Dr. Bhatt has served as a member of the National Institutes of Health Grant Review Board.

Jacqueline Corbelli

Brightline

Jacqueline Corbelli is a Founder, Chairman, Chief Executive Officer at BrightLine and is based in Brightline. She works or has worked at CNBC.

Barry Litwin

Glocal Initiative